TrialJournal of diabetes science and technology2019

A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes.

Melanie Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.